Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nedaplatin/Docetaxel vs Cisplatin/Docetaxel in Squamous Cell Lung Cancer
NCT02643407Phase 3Unknown
- Sponsor
- Guangdong Association of Clinical Trials
- Start
- Oct 2015
- Primary completion
- Dec 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of nedaplatin in squamous cell carcinoma of the lung (LSCC), sponsored by Guangdong Association of Clinical Trials. Status: unknown.
02
Drugs
nedaplatin
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT02643407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02643407.